Financial Year |
March 31 2023 |
Monetary Funds |
1,291,325,552.72 |
Held-for-trading Financial Assets |
117,310.11 |
Notes Receivable |
55,781,952.35 |
Accounts Receivable |
1,917,105,230.41 |
Advances to Suppliers |
178,149,285.05 |
Other Receivables |
801,407,720.52 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
2,647,972,100.43 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
185,963,091.38 |
Total Current Assets |
7,122,767,014.98 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
2,748,542,877.67 |
Fixed Assetes |
3,673,484,136.65 |
Under-construction Projects |
216,552,801.79 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
785,465.17 |
Oil and Gas Assets |
-- |
Intangible Assets |
518,206,969.87 |
R&D expenses |
-- |
Goodwill |
106,350,551.22 |
Long-Term Deferred and Prepaid Expenses |
81,351,891.45 |
Deferred Income Tax Assets |
95,901,705.57 |
Other Non-Current Assets |
14,411,627.87 |
Sub-Total of Non-Current Assets |
7,678,038,843.98 |
Total Assets |
14,800,805,858.96 |
Short-Term Loans |
26,009,225.00 |
Trading Financial liabilities |
-- |
Notes Payable |
35,240,876.68 |
Accounts Payable |
2,216,538,679.18 |
Accounts Received In Advance |
63,306,530.50 |
Employee Compensation Payable |
174,075,763.26 |
Taxes Payable |
984,880,383.34 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
1,338,167,322.37 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
38,103,861.27 |
Other Current Liabilities |
85,321,409.97 |
Sub-Total of Current Liabilities |
5,157,359,239.77 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
842,705,214.88 |
Special Payable |
-- |
Estimatied Liabilities |
979,811,157.25 |
Deferred Income Tax Liabilities |
54,991,269.07 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
2,713,114,430.66 |
Total Liabilities |
7,870,473,670.43 |
Paid-In Capital(Or Share Stock) |
13,863,866,690.00 |
Capital Surplus |
18,782,884,741.70 |
Surplus Reserve |
1,525,575,798.27 |
LESS:Treasury Stock |
1,222,087,272.10 |
Undistributed Profits |
-26,053,816,537.39 |
Minority Stockholder's Interest |
32,477,721.11 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,897,854,467.42 |
Owner's Equity(Stockholder's Equity) |
6,930,332,188.53 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
14,800,805,858.96 |